Is EINECS 207-048-3 Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use EINECS 207-048-3? Is EINECS 207-048-3 safe for nursing mother and child? Does EINECS 207-048-3 extracts into breast milk? Does EINECS 207-048-3 has any long term or short term side effects on infants? Can EINECS 207-048-3 influence milk supply or can EINECS 207-048-3 decrease milk supply in lactating mothers?

• DrLact safety Score for EINECS 207-048-3 is 5 out of 8 which is considered Unsafe as per our analyses.
• A safety Score of 5 indicates that usage of EINECS 207-048-3 may cause serious side effects in breastfed baby.
• Our study of different scientific research indicates that EINECS 207-048-3 may cause moderate to high side effects or may affect milk supply in lactating mother.
• Our suggestion is to use safer alternate options rather than using EINECS 207-048-3 .
• It is recommended to evaluate the advantage of not breastfeeding while using EINECS 207-048-3 Vs not using EINECS 207-048-3 And continue breastfeeding.
• While using EINECS 207-048-3 Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
• Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Progestogen with antiandrogenic properties that is used for the treatment of conditions with hypersexuality, prostate carcinoma, transsexualism and, together with ethinyl estradiol, for hirsutism, acne and alopecia and hyperandrogenism in women. It is excreted into breast milk in small quantities (Stoppelli 1980), but their anti-androgenic effects could be clinically significant for the infant when doses of 50 milligrams per day or higher are used. The small amount (2 mg) contained in contraceptive tablets in which it is combined with ethinyl estradiol would represent a very low risk and would be compatible with breastfeeding.